Yuling Luo
Founder of Alamar Biosciences
Fremont, California
Overview
Work Experience
Founder, Chairman & CEO
2018 - Current
Venture Partner, Illumina Ventures, 1/2020 - present Co-Founder & Chairman of BOD, Aopia Biosciences, 11/2019 - present Co-Founder & board member, Attovia Therapeutics, 2022 - present
Alamar Biosciences develops technologies for the detection and treatment of cancer and other diseases at the earliest possible time.
Raised $222,000,000.00 from Sands Capital Ventures, Pura Vida Investments, Sherpa Healthcare Partners and Qiming Venture Partners.
Co-Founder & Chairman of BOD
2019 - 2022
Avida Biomed was acquired by Agilent in Dec 2022
Avida Biomed aims to advance molecular diagnostics through genomic tool innovation and integration.
President, Advanced Cell Diagnostics
2016 - 2018
Retired in Feb 2018
Bio-Techne is a supplier of tools for life science research, therapeutic manufacturing, and clinical diagnostics.
Founder, President & CEO
2006 - 2016
ACD was acquired by Bio-Techne in Aug 2016
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Raised $40,800,000.00 from Summit Partners, Morningside Group, New Leaf Venture Partners and Kenson Ventures.
Founder & VP
2001 - 2009
Panomics was acquired by Affymetrix in 2008 Senior Advisor 2006-2009 Founder & VP 2001-2006
Senior Scientist
1997 - 2000
Exelixis works is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases.
Raised $514,000,000.00 from Deerfield, Silicon Valley Bank and Deerfield.